Found: 24
Select item for more details and to access through your institution.
Quality of Life in Huntington's Disease: Critique and Recommendations for Measures Assessing Patient Health-Related Quality of Life and Caregiver Quality of Life.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Growth and renal function dynamics of renal oncocytomas in patients on active surveillance.
- Published in:
- BJU International, 2021, v. 128, n. 6, p. 722, doi. 10.1111/bju.15499
- By:
- Publication type:
- Article
A Remote Digital Monitoring Platform to Assess Cognitive and Motor Symptoms in Huntington Disease: Cross-sectional Validation Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's disease.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 574, p. 1, doi. 10.1126/scitranslmed.abc2888
- By:
- Publication type:
- Article
Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 458, p. 1, doi. 10.1126/scitranslmed.aat7108
- By:
- Publication type:
- Article
Characterizing White Matter in Huntington's Disease.
- Published in:
- Movement Disorders Clinical Practice, 2020, v. 7, n. 1, p. 52, doi. 10.1002/mdc3.12866
- By:
- Publication type:
- Article
Comparison of the Huntington's Disease like 2 and Huntington's Disease Clinical Phenotypes.
- Published in:
- Movement Disorders Clinical Practice, 2019, v. 6, n. 4, p. 302, doi. 10.1002/mdc3.12742
- By:
- Publication type:
- Article
Rating Scales and Performance‐based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and Recommendations.
- Published in:
- Movement Disorders Clinical Practice, 2018, v. 5, n. 4, p. 361, doi. 10.1002/mdc3.12617
- By:
- Publication type:
- Article
Tetrabenazine Versus Deutetrabenazine for Huntington's Disease: Twins or Distant Cousins?
- Published in:
- Movement Disorders Clinical Practice, 2017, v. 4, n. 4, p. 582, doi. 10.1002/mdc3.12483
- By:
- Publication type:
- Article
Thromboprophylaxis With Apixaban in Patients Undergoing Major Orthopedic Surgery: Meta-Analysis and Trial-Sequential Analysis.
- Published in:
- Clinical Medicine Insights: Blood Disorders, 2017, n. 10, p. 1, doi. 10.1177/1179545X17704660
- By:
- Publication type:
- Article
Efficacy and safety of intravitreal anti‐tumour necrosis factor drugs in adults with non‐infectious uveitis – a systematic review.
- Published in:
- Acta Ophthalmologica (1755375X), 2018, v. 96, n. 6, p. e665, doi. 10.1111/aos.13699
- By:
- Publication type:
- Article
Cerebrospinal fluid flow dynamics in Huntington's disease evaluated by phase contrast MRI.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 12, p. 1632, doi. 10.1111/ejn.14356
- By:
- Publication type:
- Article
Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington's disease.
- Published in:
- PLoS ONE, 2020, v. 15, n. 8, p. 1, doi. 10.1371/journal.pone.0233820
- By:
- Publication type:
- Article
Longitudinal evaluation of proton magnetic resonance spectroscopy metabolites as biomarkers in Huntington's disease.
- Published in:
- Brain Communications, 2022, v. 4, n. 6, p. 1, doi. 10.1093/braincomms/fcac258
- By:
- Publication type:
- Article
Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington's disease.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-83000-x
- By:
- Publication type:
- Article
Cardiac Harms of Sofosbuvir: Systematic Review and Meta-Analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease.
- Published in:
- Journal of Neurochemistry, 2021, v. 158, n. 2, p. 539, doi. 10.1111/jnc.15360
- By:
- Publication type:
- Article
Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease.
- Published in:
- Journal of Neurochemistry, 2021, v. 158, n. 1, p. 539, doi. 10.1111/jnc.15360
- By:
- Publication type:
- Article
Reply to: An MDS Evidence-Based Review on Treatments for Huntington's Disease.
- Published in:
- 2022
- By:
- Publication type:
- letter
Neurofilament Light Protein as a Potential Blood Biomarker for Huntington's Disease in Children.
- Published in:
- Movement Disorders, 2022, v. 37, n. 7, p. 1526, doi. 10.1002/mds.29027
- By:
- Publication type:
- Article
An MDS Evidence‐Based Review on Treatments for Huntington's Disease.
- Published in:
- Movement Disorders, 2022, v. 37, n. 1, p. 25, doi. 10.1002/mds.28855
- By:
- Publication type:
- Article
Development of a solar concentrator with tracking system.
- Published in:
- Mechanical Sciences, 2016, v. 7, n. 2, p. 233, doi. 10.5194/ms-7-233-2016
- By:
- Publication type:
- Article
Overall Survival and Causes of Death in Neurodegeneration--An Overlooked and Underreported Theme.
- Published in:
- JAMA Neurology, 2017, v. 74, n. 11, p. 1379, doi. 10.1001/jamaneurol.2017.2862
- By:
- Publication type:
- Article
Natural history and burden of Huntington's disease in the UK: A population‐based cohort study.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 8, p. 2249, doi. 10.1111/ene.15385
- By:
- Publication type:
- Article